LAURA GREGORY: Open Payments
NPI 1033722970 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,795 in 84 payments from 12 companies in 2025. Trend: 2023 $19 · 2024 $1,005 · 2025 $1,795
Food & beverage: $1,795
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 31 | $690 |
| ViiV Healthcare Company | 17 | $365 |
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| Lilly USA, LLC | 7 | $155 |
| Merck Sharp & Dohme LLC | 4 | $91 |
| PFIZER INC. | 5 | $88 |
| Novo Nordisk Inc | 4 | $73 |
| Amgen Inc. | 3 | $56 |
| Exact Sciences Corporation | 2 | $46 |
| Seqirus USA Inc | 1 | $21 |
Products named: CABENUVA, MOUNJARO, Biktarvy, PIFELTRO, AIRSUPRA, PREVNAR 20, Wegovy, APRETUDE.
Industry payments across NC — which companies pay providers there.
